Skip to main content

What the FDA labels say about taking them together

Carbamazepine and nevirapine

Nevirapine's FDA label of July 15, 2026 names carbamazepine in its drug interactions section; the carbamazepine labels PlainMeds reads (3) do not name nevirapine. The nevirapine label: “Anticonvulsants: Carbamazepine, clonazepam, ethosuximide Plasma concentrations of nevirapine and the anticonvulsant may be decreased.”

Check it at the source: the carbamazepine FDA label on DailyMed (effective August 20, 2026, Novartis Pharmaceuticals Corporation); the nevirapine FDA label on DailyMed (effective July 15, 2026, Mylan Pharmaceuticals Inc.).

What does the carbamazepine label say about nevirapine?

Carbamazepine's label (effective August 20, 2026) and its 2 other brand-application labels do not name nevirapine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Tegretol), Novartis Pharmaceuticals Corporation, effective August 20, 2026 (SPL set 8d409411-aa9f-4f3a-a52c-fbcb0c3ec053), via openFDA; the full label on DailyMed

What does the nevirapine label say about carbamazepine?

Nevirapine label, drug interactions

Anticonvulsants: Carbamazepine, clonazepam, ethosuximide Plasma concentrations of nevirapine and the anticonvulsant may be decreased.

Source: FDA drug label (Nevirapine), Mylan Pharmaceuticals Inc., effective July 15, 2026 (SPL set c6e93829-7024-48f6-8023-da6ff27dfc0a), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

42Carbamazepine generic labelers
6Nevirapine generic labelers
CarbamazepineNevirapine
Labeled forBipolar disorder, Seizures and epilepsyHIV
Boxed warningYesYes
Pharmacy cost (NADAC)$0.119 per tablet 200 mg tablet$0.147 per tablet 200 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?